Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis

Research output: Contribution to journalReview articlepeer-review

Abstract

The motor neuron disease amyotrophic lateral sclerosis (ALS) is a devastating condition with limited treatment options. The past few years have witnessed a ramping up of translational ALS research, offering the prospect of disease-modifying therapies. Although breakthroughs using gene-targeted approaches have shown potential to treat patients with specific disease-causing mutations, the applicability of such therapies remains restricted to a minority of individuals. Therapies targeting more general mechanisms that underlie motor neuron pathology in ALS are therefore of considerable interest. ALS pathology is associated with disruption to a complex array of key cellular pathways, including RNA processing, proteostasis, metabolism and inflammation. This Review details attempts to restore cellular homeostasis by targeting these pathways in order to develop effective, broadly-applicable ALS therapeutics.
Original languageEnglish
Pages (from-to)1-17
JournalNature Reviews Neurology
DOIs
Publication statusPublished - 2 Jan 2025

Fingerprint

Dive into the research topics of 'Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis'. Together they form a unique fingerprint.

Cite this